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Abstract. We introduce a database containing peptides related to dis-
eases arising from protein aggregation. The general database AmyLoad
includes all experimentally studied protein fragments that could be in-
volved in erroneous protein folding, leading to amyloid formation. The
database has been extended since its first release with regard to new in-
stances of peptides or their fragments. Moreover, information of related
diseases have been added to all entries, whenever available. Currently the
database includes all available peptides tested for their potential amyloid
properties, obtained from diverse resources, creating the largest dataset
available at one place. This enables comparison between properties of
amyloid and non-amyloid peptides. We could also select candidates for
the most pathogenic peptides, involved in several diseases related to pro-
tein aggregation. We also discuss a need for sub-databases of different
structures, such as related to βγ-crystallins - a protein family occurring
in the eye lens. Misfolding of these proteins may lead to various forms of
cataract. Those freely available internet services can facilitate finding the
link between a protein sequence, its propensity to aggregation and the
resulting disease, as well as support research on their pharmacological
treatment and prevention.
1 Introduction
Many diseases, especially neurodegenerative, result from protein fragments form-
ing aggregates. This occurs when a cell environment fosters the partial unfolding
of protein chains or their fragmentation, in a way that the parts prone to joining
with other protein fragments are exposed. For the majority of proteins, consider-
able conformational rearrangement must have occurred to initiate the aggrega-
tion process. Such changes cannot take place in the typical tightly packed native
protein conformation, due to the constraints of the tertiary structure. Thus, for-
mation of a non-native partially unfolded conformation is required, presumably
enabling specific intermolecular interactions, including electrostatic attraction,
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hydrogen bonding and hydrophobic contacts. This partial unfolding can be influ-
enced by various factors, such as protein high concentration, high temperature,
low pH, binding metals, or exposition to UV light.
Initially, the resulting molecules form clusters consisting of a few elements,
which are called oligomers. Next, they grow into larger aggregates. Aggregation
of proteins or their fragments may lead to amorphous (unstructured) clusters
or amyloid (highly ordered) unbranched fibrils. Independently of the protein
sequence and its original structure, aggregates always display a common cross-
β structure. The distinctive structure of the steric zipper enables the selective
detection of amyloids from amorphous aggregates using either a variety of mi-
croscopic techniques or fluorescence of probes with which they form compounds.
Amyloid fibrils have been observed in the brains of people suffering from
Alzheimer’s disease. They are also associated with Parkinson’s disease, amy-
otrophic lateral sclerosis and Huntington’s disease, as well as many other con-
ditions, even non-neurodegenerative diseases such as type 2 diabetes and some
types of cataract. Cells in tissues containing these fibrils exhibit very high mor-
tality. However, the reasons for this cytotoxicity have not been resolved. In recent
years the occurrence rate of diseases characterized by accumulation of protein
deposits has increased significantly. These disorders are sometimes called dis-
eases of civilization since they are more prevalent in developed countries where
life expectancy is higher. Unfortunately, their mechanisms are still poorly un-
derstood. Although studies indicate that these diseases to some extent have a
genetic basis, the influence of lifestyle cannot be excluded. Unfortunately disso-
lution of peptide aggregates is very difficult, especially for amyloids which are
resistant to activity of proteolytic enzymes and chemical compounds due to the
specific and highly ordered structure of their steric zipper.
Cataract is among the diseases associated with protein aggregation. Age-
related cataract is a major burden on public health: this is the most common
cause of blindness worldwide, affecting tens of millions of people. The lens fibre
cells are essentially composed of crystallin proteins, which are among the most
highly concentrated intracellular proteins in the human body. βγ-crystallins de-
fine a superfamily of crystallins sharing similar sequence and structure. Despite
a large set of literature concerning the family of βγ-crystallins, there is no ded-
icated service containing all available genotypic and phenotypic data, as well
as tools for resolving molecular mechanisms of the disease and supporting the
development of potential pharmacological treatments.
Currently, it is believed that short peptide sequences of amyloidogenic prop-
erties (called hot-spots) can be responsible for aggregation of amyloid proteins.
These 4-10 residue long fragments (typically hexapeptides) have a high propen-
sity for strong interactions that lead to protein aggregation. Previous studies
have suggested that amyloidogenic fragments may have regular characteristics,
not only with regard to averaged physicochemical properties of their amino acids,
but also the order of amino acids in the sequence. There have been attempts to
predict the sequence of such peptides by computational modelling. Physics and
chemistry based models have been used, including FoldAmyloid [1]. This method
is based on the density of the protein contact sites. Other methods perform
threading a peptide on an amyloid fiber backbone, followed by determination
of its energy and stability [2][3][4]. Statistical approaches include production of
frequency profiles, such as the WALTZ method [5] and machine learning meth-
ods, which have been used by our team [6][7]. Some other approaches, mostly
biophysical-based, enable classification of hot spots for non-amyloid aggregation.
Recently, AGGRESCAN3D has been proposed to estimate more accurately ag-
gregation propensity by performing 3D structure based analysis [8]. All of these
methods, although promising, have faced difficulties due to limited amount of
experimental data available for their construction and validation.
Knowledge in the field of diseases related to protein aggregation is still patchy,
no global view of the problem is available and the link between the molecular
level and the phenotype is still generally missing. In addition, although a large
amount of information is available, its dispersion in separate publications, data
sets and web services hampers research development. To fill in this gap, we pro-
posed a new web service, AmyLoad [9], which is devoted to protein aggregation
and can facilitate global research in the field. The service is focused on general
amyloidogenic peptides. However studies on specific cataract related aggregation
have led us to the idea of separate sub-database services, including more specific
and detailed information, even if some is only predicted by software tools.
2 Results
AmyLoad is a website which gathers information about known, experimentally-
derived, amyloidogenic and non-amyloidogenic amino acid protein fragments [9].
The data comes from literature studies and various data sources, which are
WALTZ-DB [5], AmylFrag, AmylHex [10], and datasets used to validate such
methods like TANGO [11] and AGGRESCAN [12]. Although these data sources
contain protein fragments according to different specific features, the fact that
one fragment can belong to more than one dataset makes these databases dif-
ficult to work with. In addition, data filtration is usually unavailable. In this
category of datasets WALTZ-DB and AmylHex contain only protein fragments
which are composed of six amino acids. AmylFrag possesses 45 literature-derived
fragments which are longer than six residues. TANGO and AGGRESCAN are
well known amyloidogenicity prediction methods, which are based on different
sequence analysis algorithms. They were also validated using original experi-
mental data. TANGO uses statistical mechanics algorithm based on the physic-
ochemical principles of beta-sheet formation to predict protein aggregation. It
was tested on a set of 179 peptides obtained from the literature and 71 new
peptides derived from human disease-related proteins [11]. Alternatively, AG-
GRESCAN takes advantage of the aggregation-propensity scale for amino acids.
It was trained on a database of 57 experimentally known amyloidogenic proteins
[12]. These training data have been included into our database.
The website was built using the Django web framework and a MySQL database.
Figure 1 presents the AmyLoad database tables and relations between them. The
most important table contains detailed information about each fragment such as
name, residue sequence, aggregation ability, experimental conditions, and data
about its first occurrence in the database: user and date. Each protein frag-
ment is related to only one protein record stored in another table. While there
can be more than one protein fragment related to a single protein record, the
residue sequence and protein record id attributes are unique for each record of
the protein fragment. Other tables store information about references related to
the record of the fragment, datasets of origin, experimental methods used for
their discovery, and their saves in private users sessions. Records of these tables
are in many-to-many relation with protein fragment record. Information about
registered users and administrators are stored securely taking advantage of the
common user authentication system provided by Django.
The principal function of the AmyLoad website is data browsing and filter-
ing. Currently, the data can be filtered according to protein name, aggregation
propensity, residue sequence length, and sequence substring. Selected fragment
records can be moved to the temporary session field where they can be saved
for later studies. The data about selected fragments can be downloaded in sev-
eral file formats, such as the CSV, SSV (Semicolon Separated Values), XML,
and FASTA. The SSV and XML files contain all information gathered in the
database for selected fragments. The CSV file includes only that information
which is visible in the browsing table, i.e. protein name, fragment name, residue
sequence, and aggregation propensity. The FASTA file contains information in
the FASTA format, which is well known for those who work in bioinformatics.
It is a text-based format which represents nucleotide or protein sequences as a
single-letter code. Each sequence in the FASTA format can be preceded with
an additional sequence information line which begins with the greater-than (>)
symbol. In the AmyLoad website, that line contains the AmyLoad index, protein
name, and fragment name.
New fragments can be submitted into the database in two ways by either
filling in the website form or uploading a file in a proper XML format. The first
option is recommended for the submission of a single fragment which has no
more than one reference and dataset of origin. This is the most common manner
of fragment submission. Taking advantage of the XML format, users can add
at once multiple fragment records including potentially several references and
datasets of origin each. The AmyLoad XML format is explained in details on
the help page where examples and downloadable files are provided. Submitted
fragments are visible to the general public only after reviewer approval. Until
then, they are only accessible on the personal web page of the user who submitted
them.
Following submission of protein sequences in the FASTA format, the Amy-
Load website allows for their analysis with several implemented amyloidogenicity
predictors, i.e. FoldAmyloid [1], AGGRESCAN, and FISH [7]. Implementations
of all these methods were validated through comparison of their results with
those of their original online implementations. FoldAmyloid and AGGRESCAN
are based on sliding window algorithms. FoldAmyloid analyzes experimentally-
Fig. 1. AmyLoad database structure
derived expected probability of hydrogen bonds formation and expected pack-
ing density of amino acids in the sequence of interest [1]. AGGRESCAN, on
the other hand, calculates the aggregation-propensity scale for residues derived
from in vivo experiments [12]. Finally, FISH is a machine learning method which
was created in our group, based on the site-specific co-localization of aminoacid
pairs. The results of the analysis for any of the chosen methods are sent by email
to users using a binary format, where 1 means that the associated residue in the
submitted sequence belongs to the amyloidogenic fragment. Together with the
implemented methods, AmyLoad allows its users to search its database for se-
quence fragments which occur in submitted FASTA sequences. The advantage
of using the AmyLoad implementations instead of the original modelling tools
is that users can run calculations for several submitted fragments at once. In
addition, results of different methods are presented in the email in a comparable
format which makes AmyLoad a simple consensus amyloidogenicity predictor.
On the analysis website, references and links to the original implementations of
FoldAmyloid, AGGRESCAN, FISH, and other 13 well known amyloidogenicity
predictors are also provided.
There are three types of users interacting with the AmyLoad website. The
first one is the common non-registered user who can use the entire analysis web-
site, and browse and filter the data about sequence fragments gathered in the
database. The second one is a registered user who can create temporary sessions
and save them for later studies. Furthermore, only the registered user is able
to submit new fragments into the database. Finally, there are the database ad-
ministrators who have all the privileges of non-registered and registered users,
together with the ability to review the submitted fragments. Only after the
administrator-reviewer approval, a fragment becomes visible to the general pub-
lic on the browsing web page.
Currently, there are 1477 unique entries in the AmyLoad database, which
come from over 150 different proteins. Figure 2 shows the distribution of sequence
lengths within the deposited fragments. The website contains also information
about almost 100 references related to the amyloidogenicity topic. According
to the literature, peptide fragments deposited in the AmyLoad were analysed
by almost 20 different experimental methods such as electron microscopy or
thioflavin dyeing.
Collecting all sequences diagnosed for amyloidogenicity enabled finding a
pattern in the contents of amyloid and non-amyloid fragments. We tested sev-
eral sets of peptides within different length ranges. Exemplary results are shown
in Fig. 3 (hexapeptides which are the best studied with regard to their aggre-
gation propensity) and in Fig. 4 (fragments of all lengths). The study showed
that amyloid fragments are rich in valine (V), isoleucine (I), leucine (L) and
phenyloalanine (F), which appeared in the instances of almost all lengths. It
proves an excess of non-polar neutral aminoacids with high propensity to form
beta strands. Interestingly, non-amyloidogenic peptides are characterized with
increased contents of non-polar charged aminoacids, especially positively charged
lysine (K) and arginine (R), and to lesser extent negatively charged aspartic acid
Fig. 2. Lengths of fragments deposited in AmyLoad
(D) and glutamic acid (E). Enrichement of peptides with charged aminoacids
impacts on their non-amyloidogenic properties, which may be considered for
applications towards changing the amyloidogenic properties of peptides.
The database has been extended by diseases related to amyloid fragments.
It enabled to observe that majority of the fragments (44) are related to the
Alzheimer’s disease, then to prion diseases (26 fragments), type II diabetes (20
fragments), dialysis-related amyloidosis (16 fragments), and Amyotrophic Lat-
eral Sclerosis (11 fragments). Interesingly, some of the amyloidogenic fragments
have been shown as involved in up to three diseases. These include certain
fragments of alpha synuclein - 8 fragments of this protein can lead either to
Alzheimer’s disease, or Parkinson’s disease, or dementia with Lewy bodies. An-
other protein involved in 3 different diseases is τ -protein - with 6 fragments that
can lead to Alzheimer’s disease, Pick’s disease, and progressive supranuclear
palsy. However, a number of entries has not been associated with any disease,
yet.
A general database, such as AmyLoad cannot contain sequences that have
not been experimentally confirmed with regard to their misfolding properties,
even though they may contribute to understanding of a disease. On the other
hand, several protein features could be predicted with modelling tools, which
would be very helpful in studying molecular mechanisms of the diseases of in-
terest. Such information is produced by specific modelling tools and it is asso-
ciated with some uncertainty, especially when predictors produce contradicting
results. As a consequence it needs to be very carefully examined and tagged in a
database. Although addition of modelling results could be considered for a gen-
eral database such as AmyLoad, this would require an immense amount of work
Fig. 3. Amino acid contents in hexapeptides collected in AmyLoad. Black bars denote
amyloid fragments, grey non-amyloid, white bars statistical frequency as in Uniprot
database
Fig. 4. Amino acid contents in all fragments collected in AmyLoad. Black bars denote
amyloid fragments, grey non-amyloid, white bars statistical frequency as in Uniprot
database
of the database curators to add these results with regard to every protein poten-
tially aggregating, taking into account all available modelling tools. We believe
that general databases should include less information, i.e. fewer fields, but from
more reliable sources. Therefore, we decided to include only experimental data
into AmyLoad and extend it into related subdatabases, dedicated to specific
protein families that may be of research interest with regard to certain diseases.
The first such database will be devoted to the βγ-crystallins and their involve-
ment in cataract development. One of the specificities of these proteins is their
aggregation pathway: many crystallins that are involved in the development of
cataract can form amorphous aggregates rather than amyloids, others follow an
amyloid aggregation path, whereas some may be involved in both paths. The
sub-database of crystallins will separate and extend the number of their current
entries in AmyLoad, while increasing the amount of available information about
each of them.
3 Conclusions
We reported an internet database system dedicated to aggregating peptides,
which may underlie several diseases of civilization, such as neurodegenerative
diseases, diabetes type 2, and cataract. The general peptide database AmyLoad
contains all currently known sequences of aminoacids whose propensity to amy-
loid aggregation has been published, based on experimental results. The entries
also include some more specific information regarding each record.
Analysis of the amyloidogenic peptides, collected in the database showed a
strong excess of neutral non-polar aminoacids with high propensity to for beta
strands, such as valine, isoleucine, leucine and phenyloalanine. It appeared in
the instances of all lengths. Interestingly, non-amyloidogenic peptides are char-
acterized with increased contents of aminoacids with a positive charge and to
lesser extent of negative charge. Since the enrichement of peptides with charged
aminoacids impacts on non-amyloidogenic properties of peptides, it may be con-
sidered for applications towards changing the amyloidogenic properties of pep-
tides.
AmyLoad may be too general for a specific family of proteins related to
diseases in which aggregation may assume different forms, or modelling results
would be crucial for further studies. Hence, more specialized sub-databases of
different fields and including modelling results are required, such as the one
containing βγ-crystallin proteins - underlying various forms of cataract. The
sub-database should allow more detailed information than AmyLoad, focused
more on different aggregate structures, leading to different disease phenotypes
and different potential treatments for which pharmacophores could be designed
based on available data.
Databases of aggregating proteins are needed to support further research in
related diseases. We believe that our freely available internet service will facili-
tate the identification of the link between a protein sequence, its propensity to
aggregation and the resulting disease, and discovering molecular events behind
development of diseases related to protein aggregation, as well as their pharma-
cological treatment and prevention.
The AmyLoad database, as well as other tools, could be found at Comprec
server: http://comprec-lin.iiar.pwr.edu.pl/amyload/
Acknowledgements This work was in part supported by the grant N N519
643540 from National Science Centre of Poland.
References
1. Garbuzynskiy, SO., Lobanov, MY., Galzitskaya, OV. FoldAmyloid: a method of pre-
diction of amyloidogenic regions from protein sequence. Bioinformatics 26(3):326–32
(2010).
2. Goldschmidt, L., Tenga, PK., Riek, R., Eisenberg, D.: Identifying the amylome,
proteins capable of forming amyloid-like fibrils. PNAS 107:3487–3492 (2010).
3. Bryan, AW Jr., O’Donnell, CW., Menke, M., Cowen, LJ., Lindquist, S., Berger,
B.: STITCHER: Dynamic assembly of likely amyloid and prion -structures from
secondary structure predictions. Proteins 80:410–420 (2011).
4. O’Donnell, CW., Waldispu¨hl, J., Lis, M., Halfmann, R., Devadas, S., Lindquist, S.,
Berger, B.: A method for probing the mutational landscape of amyloid structure.
Bioinformatics 27:i34–42 (2011).
5. Beerten, J., Van Durme, J., Gallardo, R., Capriotti, E., Serpell, L., Rousseau, F.,
Schymkowitz, J.: WALTZ-DB: a benchmark database of amyloidogenic hexapep-
tides. Bioinformatics 31(10):1698–700 (2015).
6. Stanislawski, J., Kotulska, M., Unold, O.: Machine learning methods can replace 3D
profile method in classification of amyloidogenic hexapeptides. BMC Bioinformatics
14:21 (2013).
7. Gasior, P., Kotulska, M.: FISH Amyloid - a new method for finding amyloidogenic
segments in proteins based on site specific co-occurrence of aminoacids. BMC Bioin-
formatics 15:54 (2014).
8. Zambrano, R., Jamroz, M., Szczasiuk, A., Pujols, J., Kmiecik, S., Ventura, S.: AG-
GRESCAN3D (A3D): server for prediction of aggregation properties of protein
structures. Nucleic Acids Research (2015), doi: 10.1093/nar/gkv359
9. Wozniak, PP., Kotulska, M.: AmyLoad - website dedicated to amyloidogenic
protein fragments. Bioinformatics (2015), doi: 10.1093/bioinformatics/btv375.
http://comprec-lin.iiar.pwr.edu.pl/amyload/
10. Thompson, MJ., Sievers, SA., Karanicolas, J., Ivanova, MI., Baker, D., Eisenberg,
D.: The 3D profile method for identifying fibril-forming segments of proteins. Proc.
Natl. Acad. Sci. U.S.A. 103(11), 4074–8 (2006).
11. Fernandez-Escamilla, AM., Rousseau, F., Schymkowitz, J., Serrano, L.: Prediction
of sequence-dependent and mutational effects on the aggregation of peptides and
proteins. Nat. Biotechnol. 22(10), 1302–6 (2004).
12. Conchillo-Sol, O., de Groot, NS., Avils, FX., Vendrell, J., Daura, X., Ventura,
S.: AGGRESCAN: a server for the prediction and evaluation of ”hot spots” of
aggregation in polypeptides. BMC Bioinformatics, 8:65 (2007).
